Concentration (μM) | Number of experiments | % Inhibition ofa HIV-1 replication (mean ± SE) | % Viabilityb no HIV-1 Infection (Trypan blue) | % Viabilityc HIV-1 Infection (Annexin V) |
---|---|---|---|---|
WR1065 | Â | Â | Â | Â |
   26 | 5 | 65.0 ± 7.5 | 77.8 ± 4.2 | 95.8 ± 0.5 |
   52 | 7 | 88.7 ± 5.5 | 49.3 ± 3.8 | 92.5 ± 1.1 |
   103 | 8 | 93.9 ± 3.1 | 36.8 ± 17.1 | NDd |
Amifostine | Â | Â | Â | Â |
   50 | 4 | 75.4 ± 8.3 | 53.2 ± 9.6 | NDd |